Evidence map›Paper›PMID 41602305›Full record

ArticleFrontiers in artificial intelligence2025

The collaborations among healthcare systems, research institutions, and industry on artificial intelligence research and development.

Jiancheng Ye, Michelle Ma, Malak Abuhashish

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Digital health technology burden and frustration among patients with multimorbidity.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  2. Foundation models for cardiovascular diseases and medicine.European heart journal. Digital health · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiancheng YeWeill Cornell Medicine, Cornell University, New York, NY, United States.
Michelle MaWeill Cornell Medicine, Cornell University, New York, NY, United States.
Malak AbuhashishWeill Cornell Medicine, Cornell University, New York, NY, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The integration of Artificial Intelligence (AI) in healthcare promises to revolutionize patient care, diagnostics, and treatment protocols. Collaborative efforts among healthcare systems, research institutions, and industry are pivotal to leveraging AI's full potential. Understanding these dynamics is essential for addressing current challenges and shaping future AI development in healthcare. This study aims to characterize collaborative networks and stakeholders in AI healthcare initiatives, identify challenges and opportunities within these collaborations, and elucidate priorities for future AI research and development. Methods: This study analyzed publicly available survey data previously collected by the Chinese Society of Radiology and the Chinese Medical Imaging AI Innovation Alliance. We performed secondary analysis of the national cross-sectional survey that was conducted in China with a total of 5,262 participants (5,142 clinicians and 120 research institution professionals), involving participants from three key groups: clinicians, institution professionals, and industry representatives. The survey explored diverse aspects including current AI usage in healthcare, collaboration dynamics, challenges encountered, and research and development priorities. Results: Findings reveal high interest in AI among clinicians, with a significant gap between interest and actual engagement in development activities. Key findings include limited establishment of AI research departments and scarce interdisciplinary collaborations. Despite the willingness to share data, progress is hindered by concerns about data privacy and security, and lack of clear industry standards and legal guidelines. Future development interests focus on lesion screening, disease diagnosis, and enhancing clinical workflows. Conclusion: This study highlights an enthusiastic yet cautious approach toward AI in healthcare, characterized by significant barriers that impede effective collaboration and implementation. Recommendations emphasize the need for AI-specific education and training, secure data-sharing frameworks, establishment of clear industry standards, and formation of dedicated AI research departments.

Indexed as

artificial intelligencecollaborationdata privacyhealthcare systemimplementation researchindustry standardsresearch and development

Identifiers

PMID41602305
PMCPMC12832655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.